Epsilon Health Investors

Epsilon Health Investors is a venture capital firm specializing in digital healthcare investments. Founded by healthcare veterans Steven Epstein and Gregory Epstein of Epstein Becker & Green, P.C., the firm manages capital on behalf of strategic limited partners and commercial investors. With decades of experience in healthcare investing, advising, regulatory support, and board leadership, Epsilon leverages its strategic LP base and the deep experience of its founders and advisors to help portfolio companies achieve scale.

The firm employs a thematic investment approach, focusing on digital health companies that address significant pain points and inefficiencies in the healthcare system. Epsilon primarily invests in Seed+ to Series B stages, targeting sectors such as digital health, healthcare IT, and technology-enabled services. The firm is capable of leading investment rounds or participating as part of a syndicate.

Epsilon Health Investors' current portfolio includes companies like Artisight, AvoMD, Axuall, Banjo Health, Bayesian Health, Cylera, Greater Good Health, Health Gorilla, KODE Health, Luma Health, Marigold, Praia Health, RemedyLogic, Suki, and wayForward. The firm has also been involved in prior investments in companies such as Acumen Healthcare, Team Health, Syft, Cognitive Clinical Trials, Inception Fertility, Catamaran, MedExpress, BrightSpring, Restorix Health, and Solis Women's Health, serving on the board of directors in all cases.